PKTX.OTC.PinkProtokinetix, INC

Form 4: ProtoKinetix CEO Clarence Smith Acquires Additional Shares in Private Placement

Sentiment:

SEC Form 4


Clarence Edward Smith, President & CEO of ProtoKinetix, Inc., reports the acquisition of 6,500,000 shares of common stock through a private placement.

Capital raiseClarence Edward Smith acquired 6,500,000 shares of common stock through a private placement.

Summary

  • Clarence Edward Smith, the President & CEO of ProtoKinetix, Inc., has reported changes in beneficial ownership of the company's stock.
  • On June 13, 2024, Smith acquired 3,400,000 shares of common stock at a price of $0.01 per share through a private placement.
  • On June 14, 2024, Smith acquired an additional 3,100,000 shares of common stock at a price of $0.01 per share through a private placement.
  • Following these transactions, Smith directly owns 68,214,444 shares of common stock.
  • Smith also indirectly owns 13,572,649 shares through the Clarence E. Smith Trusts and 1,850,000 shares through his retirement account.
  • Smith also holds options to purchase 32,350,000 shares of common stock at an exercise price of $0.028, exercisable on December 6, 2028.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares suggests confidence, but the lack of broader context makes it difficult to assess the overall impact.

Positives

  • The CEO's purchase of additional shares may signal confidence in the company's future prospects.

Risks

  • The document does not provide information on the company's overall financial health or future plans, making it difficult to assess the long-term implications of these transactions.

Industry Context

Form 4 filings are a routine part of regulatory compliance for company insiders and provide transparency into their trading activities. The purchase of shares by the CEO can be interpreted as a positive signal, but should be considered in the context of the company's overall performance and industry trends.

Stakeholder Impact

  • The CEO's increased stake could align his interests more closely with those of other shareholders.

Key Dates

DateDescription
06/13/2024Smith acquired 3,400,000 shares of common stock at $0.01 per share.
06/14/2024Smith acquired 3,100,000 shares of common stock at $0.01 per share.
06/17/2024Date of the report filing.
12/06/2028Expiration date of stock options.

Keywords

ProtoKinetix, PKTX, Clarence Smith, insider trading, beneficial ownership, private placement, stock options, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.